Atrial Fibrillation Incidence, Risk Factors and Genetics
NCT00021905 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2008-07-24
Summary
To assess the risk of incident atrial fibrillation after stopping anti-hypertensive medication including beta-blockers and ACE inhibitors. Also, to assess the role of genetics in subsequent risk of stroke among patients with atrial fibrillation.
Conditions
- Atrial Fibrillation
- Cardiovascular Diseases
- Heart Diseases
- Hypertension
- Cerebrovascular Accident
- Arrhythmia
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Susan Heckbert · University of Washington
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-07-31
- Primary Completion
- 2008-06-30
- Completion
- 2008-06-30
More Related Trials
-
Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE
NCT05293080 ·Status: RECRUITING ·Phase: PHASE3
-
Atrial Fibrillation Registry 2017
NCT05023590 ·Status: UNKNOWN ·Phase: NA
-
Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial Fibrillation
NCT01650298 ·Status: TERMINATED ·Phase: NA
-
Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring
NCT01706146 ·Status: COMPLETED ·Phase: PHASE4
-
Markers of Oxidative Stress Present in Blood in Patients With Atrial Fibrillation
NCT00142194 ·Status: COMPLETED
-
Understanding and Improving Anticoagulation Dosing for Patients With Atrial Fibrillation
NCT03719144 ·Status: COMPLETED
-
Individualized Studies of Triggers of Paroxysmal Atrial Fibrillation
NCT03323099 ·Status: COMPLETED ·Phase: NA
-
The Influence of Genetic Predisposition on Outcome After Catheter Ablation of Atrial Fibrillation.
NCT04753541 ·Status: UNKNOWN
-
Treatment and Outcomes of Atrial Fibrillation and Acute Coronary Syndrome in Sweden
NCT03311139 ·Status: COMPLETED
-
Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)
NCT03508258 ·Status: WITHDRAWN
-
A Study to Quantify Use of Anticoagulation to Improve Management of Atrial Fibrillation
NCT03382613 ·Status: TERMINATED
-
A Retrospective Analysis of the Use of ACE-inhibitors and Angiotensin Receptor Blockers
NCT00321945 ·Status: COMPLETED
-
Risk Profile for Atrial Fibrillation
NCT01510197 ·Status: COMPLETED
-
Study in Atrial Fibrillation (AF) Patients at High Risk of Stroke
NCT05421533 ·Status: TERMINATED
-
Reasons for Variations in Health Related Quality of Life and Symptom Burden in Patients With Atrial Fibrillation
NCT01553045 ·Status: UNKNOWN
-
Atrial Fibrillation Trial To Eliminate Risk-factors
NCT05718336 ·Status: COMPLETED
-
Clinical Decision Support for Atrial Fibrillation and Flutter
NCT05009225 ·Status: ACTIVE_NOT_RECRUITING
-
Reversal of Atrial Substrate to Prevent Atrial
NCT03682991 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
NCT00000556 ·Status: COMPLETED ·Phase: PHASE3
-
Genetically Determined Response to Atenolol in Patients With Persistent Atrial Fibrillation
NCT01719367 ·Status: COMPLETED ·Phase: NA
-
Atrial Fibrillation Ablation Registry
NCT04055961 ·Status: UNKNOWN
-
Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter
NCT02339493 ·Status: COMPLETED ·Phase: NA
-
Feasibility Testing of the Alert for Atrial Fibrillation Program
NCT01988974 ·Status: COMPLETED ·Phase: NA
-
Management of Antithrombotic TherApy in Patients With Atrial Fibrillation or DevelOping AtRial Fibrillation During Hospitalization for PCI
NCT03656523 ·Status: COMPLETED
-
Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control
NCT06783868 ·Status: NOT_YET_RECRUITING